Toxic epidermal necrolysis successfully treated with etanercept

J Dermatol. 2009 Mar;36(3):150-3. doi: 10.1111/j.1346-8138.2009.00616.x.

Abstract

Toxic epidermal necrolysis (TEN) is a rare and acute severe adverse reaction to drugs, characterised by massive apoptosis and widespread epidermal and mucosal detachment. Although no gold standard therapy exists, human i.v. immunoglobulins have recently been described as an effective treatment for this disease. We report a case of phenobarbital-induced TEN in a 59-year-old white woman where the epidermal detachment stopped 48 h after beginning the etanercept treatment with complete healing after 20 days. To the best of our knowledge, this is only the second reported case of TEN successfully treated with etanercept.

Publication types

  • Case Reports

MeSH terms

  • Etanercept
  • Female
  • Humans
  • Immunoglobulin G / therapeutic use*
  • Middle Aged
  • Receptors, Tumor Necrosis Factor / therapeutic use*
  • Stevens-Johnson Syndrome / drug therapy*
  • Stevens-Johnson Syndrome / pathology
  • Stevens-Johnson Syndrome / physiopathology
  • Time Factors
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / physiology

Substances

  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Etanercept